BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16705224)

  • 1. [Heart arrhythmias and congestive heart failure].
    Abuladze GV; Narciia EV; Mamamtavrishvili ND; Nikolaishvili MG; Kantariia DA
    Georgian Med News; 2006 Apr; (133):41-4. PubMed ID: 16705224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arrhythmias and heart failure].
    Amann FW; Candinas R
    Ther Umsch; 1993 Jun; 50(6):419-24. PubMed ID: 8351673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How are tachycardic cardiac arrhythmias modified by therapy of congestive heart failure?].
    Meinertz T; Hofmann T; Drexler H; Zehender M; Just H
    Herz; 1990 Jun; 15(3):207-13. PubMed ID: 2198221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacotherapy of chronic heart failure in clinical practice].
    Halawa B
    Pol Merkur Lekarski; 2004 Apr; 16(94):307-12. PubMed ID: 15517921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.
    Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart failure and treatment of ventricular arrhythmias].
    Junga G; Duru F; Candinas R
    Praxis (Bern 1994); 1999 Feb; 88(6):215-22. PubMed ID: 10081339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of ventricular arrhythmia in chronic congestive heart failure].
    Pulignano G; Giovannini M; Del Sindaco D; Fera MS; Mazza A; Minardi G; Giovannini E
    Clin Ter; 1998; 149(4):297-305. PubMed ID: 9866892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of arrhythmias in chronic cardiac insufficiency].
    Motté G; Slama M; Drieu L
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1963-6. PubMed ID: 1980188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death.
    Bigger JT
    Circulation; 1987 May; 75(5 Pt 2):IV28-35. PubMed ID: 3552300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can antiarrhythmic drugs save lives in patients with congestive heart failure?
    Brendorp B; Pedersen OD; Elming H; Køber L; Torp-Pedersen C
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):191-202. PubMed ID: 15030280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of complications: a forgotten aspect of therapy? arrhythmia complication in heart failure].
    de Sousa J
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():33-8. PubMed ID: 11409072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antiarrhythmic drugs in patients with heart failure: clinical efficacy, hemodynamic results, and relation to survival.
    Wilson JR
    Circulation; 1987 May; 75(5 Pt 2):IV64-73. PubMed ID: 3552304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of congestive heart failure treatment on incidence and prognosis of ventricular tachyarrhythmias.
    Birgersdotter-Green U; Rosenqvist M; Rydén L
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S53-8. PubMed ID: 1723120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure and disorders of the heart beat.
    Weaver T; Eisold JF
    Dent Clin North Am; 1996 Jul; 40(3):543-61. PubMed ID: 8829045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drug therapy in patients with renal failure, liver failure, and congestive heart failure.
    Chow T; Galvin J; McGovern B
    Heart Dis; 1999; 1(2):98-107. PubMed ID: 11720610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of arrhythmias in patients with chronic cardiac insufficiency with preserved left ventricular systolic function].
    Otrokhova EV
    Klin Med (Mosk); 2007; 85(4):11-7. PubMed ID: 17564029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin receptor blockers and cardiac rhythm disorders].
    Galinier M; Pathak A; Roncalli J
    Arch Mal Coeur Vaiss; 2006; 99(7-8):745-7. PubMed ID: 17061457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical approach to antiarrhythmic therapy in patients with ventricular arrhythmia.
    Reddy CP; Arnett JD
    J La State Med Soc; 1989 May; 141(5):45-8. PubMed ID: 2659710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.